QR Pharma, Inc. announced the election of Mr. Michael Hoffman as Chairman of the Board of Directors and Mr. Dhesh Govender as Director. Mr. M. B. Hoffman is a Partner of Riverstone Holdings LLC. Dhesh S.K. Govender is currently CEO and Founder of Tara Immuno-Oncology LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.85 USD | -2.66% |
|
-5.19% | -68.72% |
05-10 | Annovis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-09 | Annovis Bio, Inc. Announces Unblinding of the Buntanetap Phase III Data in Parkinson?s Disease | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.72% | 65.35M | |
+18.15% | 124B | |
+18.02% | 112B | |
+4.60% | 22.94B | |
-9.86% | 17.02B | |
-16.06% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B | |
+106.26% | 10.31B |
- Stock Market
- Equities
- ANVS Stock
- News Annovis Bio, Inc.
- QR Pharma, Inc. Appoints Management